PIPA5104807

Phospho-CD19 (Tyr531) Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5104807-Each-of-1 In Stock ₹ 46,502.50

PIPA5104807 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

Phospho-CD19 (Tyr531)

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Cd19

Gene Alias

AW495831; B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Cd19; CD19 antigen; CD19 molecule; CVID3; differentiation antigen CD19; Leu-12; T-cell surface antigen Leu-12

Host Species

Rabbit

Purification Method

sequential chromatography

Regulatory Status

RUO

Gene ID (Entrez)

12478, 930

Content And Storage

-20°C

Form

Liquid

Applications

Immunocytochemistry, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.4

Gene Accession No.

P15391, P25918

Gene Symbols

Cd19

Immunogen

A synthesized peptide derived from human CD19(Accession P15391), corresponding to amino acid residues around phosphorylated Tyr531.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Non-human Primate

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5109495

--

Img

Thermo Scientific

PIPA5104865

--

Img

Thermo Scientific

PIPA5104831

--

Img

Thermo Scientific

PIPA5105153

--

Img

Thermo Scientific

PIPA5104864

--

Img

Thermo Scientific

PIPA5104877

--

Img

Thermo Scientific

PIPA5105100

--

Img

Thermo Scientific

PIPA5104863

--

Description

  • Antibody detects endogenous levels of CD19 only when phosphorylated at Tyrosine 531
  • CD19 is a member of the immunoglobulin superfamily and has two Ig like domains
  • The CD19 molecule is expressed on 100% of the peripheral B cells as defined by expression of kappa or lambda light chains
  • CD19 appears to be expressed on myeloid leukemia cells, particularly those of monocytic lineage
  • Leukemia phenotype studies have demonstrated that the earliest and broadest B cell restricted antigen is the CD19 antigen
  • The receptor for CD19 is an important functional regulator of normal and malignant B cell proliferation, and is expressed in all B cell precursor leukemias
  • Lymphocytes proliferate and differentiate in response to various concentrations of different antigens
  • The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors
  • CD19 is a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation
  • Besides being a signal-amplifying coreceptor for the B cell receptor (BCR), CD19 can also signal independently of BCR co-ligation and is a central regulatory component upon which multiple signaling pathways converge
  • Mutation of the CD19 gene results in hypogammaglobulinemia, whereas CD19 overexpression causes B cell hyperactivity.